BUB
DXCM icon

BBVA USA Bancshares’s DexCom DXCM Stock Holding History

BBVA USA Bancshares’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-14,680
Closed -$268K – 527
2017
Q2 		$268K Buy
14,680
+276
+2% +$5.1K 0.02% 476
2017
Q1 		$305K Sell
14,404
-788
-5% -$15.4K 0.02% 450
2016
Q4 		$227K Sell
15,192
-584
-4% -$10.3K 0.02% 510
2016
Q3 		$346K Buy
15,776
+960
+6% +$21.4K 0.03% 428
2016
Q2 		$294K Sell
14,816
-2,732
-16% -$46.5K 0.02% 439
2016
Q1 		$298K Buy
17,548
+7,332
+72% +$122K 0.02% 434
2015
Q4 		$209K Buy
+10,216
New +$213K 0.02% 466

Other funds holding DXCM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BBVA USA Bancshares's DXCM Position: Q3 2017 in Review

BBVA USA Bancshares sold out of DexCom (DXCM) in Q3 2017, closing a stake of 14,680 shares — an estimated $268K sold.

BBVA USA Bancshares first reported a position in DXCM in Q4 2015 and held it in 7 quarters. The position peaked at $346K in Q3 2016. 275 funds tracked by Wall St. Rank hold DXCM as of Q3 2017.

  • BBVA USA Bancshares reported no remaining DexCom position as of Q3 2017 after selling out during the quarter.
  • BBVA USA Bancshares sold 14,680 DexCom shares in Q3 2017, an estimated $268K.
  • BBVA USA Bancshares first reported a position in DexCom in Q4 2015 and held it in 7 quarters.
  • BBVA USA Bancshares's DexCom position peaked at $346K in Q3 2016.
  • 275 funds tracked by Wall St. Rank held DexCom as of Q3 2017.

Based on BBVA USA Bancshares's 13F filing for Q3 2017, filed 30 Oct 2017.